Asymptomatic ceftriaxone‐associated pseudolithiasis

Abstract An 88‐year‐old woman with a history of meningioma and dementia was admitted with high fever, loss of appetite, and nausea in July. Urinary tract infection was suspected. Computed tomography (CT) showed no significant findings. Urinary findings improved with administration of ceftriaxone. Ho...

Full description

Bibliographic Details
Main Authors: Osamu Sasaki, Kazunori Sugimura, Masahiro Shinoda, Masaharu Shinkai
Format: Article
Language:English
Published: Wiley 2019-09-01
Series:Journal of General and Family Medicine
Subjects:
Online Access:https://doi.org/10.1002/jgf2.269
id doaj-f730661ffda14c90a291442d89a5cfe1
record_format Article
spelling doaj-f730661ffda14c90a291442d89a5cfe12020-11-24T21:50:46ZengWileyJournal of General and Family Medicine2189-79482019-09-0120520921210.1002/jgf2.269Asymptomatic ceftriaxone‐associated pseudolithiasisOsamu Sasaki0Kazunori Sugimura1Masahiro Shinoda2Masaharu Shinkai3Division of Internal Medicine Tokyo‐Shinagawa hospital Tokyo JapanDivision of Internal Medicine Tokyo‐Shinagawa hospital Tokyo JapanDivision of Internal Medicine Tokyo‐Shinagawa hospital Tokyo JapanDivision of Internal Medicine Tokyo‐Shinagawa hospital Tokyo JapanAbstract An 88‐year‐old woman with a history of meningioma and dementia was admitted with high fever, loss of appetite, and nausea in July. Urinary tract infection was suspected. Computed tomography (CT) showed no significant findings. Urinary findings improved with administration of ceftriaxone. However, high fever appeared on hospital day 28, and CT identified a gallbladder stone without any abdominal symptoms. We considered the possibility of ceftriaxone‐associated pseudolithiasis and changed pharmacotherapy to cefmetazole. CT on day 34 showed a reduction in the size of the gallbladder stone. Ceftriaxone‐associated pseudolithiasis might arise in the absence of abdominal symptoms, and clinicians should take the patient background and season into account when using this agent.https://doi.org/10.1002/jgf2.269asymptomaticceftriaxonehigh temperaturepseudolithiasis
collection DOAJ
language English
format Article
sources DOAJ
author Osamu Sasaki
Kazunori Sugimura
Masahiro Shinoda
Masaharu Shinkai
spellingShingle Osamu Sasaki
Kazunori Sugimura
Masahiro Shinoda
Masaharu Shinkai
Asymptomatic ceftriaxone‐associated pseudolithiasis
Journal of General and Family Medicine
asymptomatic
ceftriaxone
high temperature
pseudolithiasis
author_facet Osamu Sasaki
Kazunori Sugimura
Masahiro Shinoda
Masaharu Shinkai
author_sort Osamu Sasaki
title Asymptomatic ceftriaxone‐associated pseudolithiasis
title_short Asymptomatic ceftriaxone‐associated pseudolithiasis
title_full Asymptomatic ceftriaxone‐associated pseudolithiasis
title_fullStr Asymptomatic ceftriaxone‐associated pseudolithiasis
title_full_unstemmed Asymptomatic ceftriaxone‐associated pseudolithiasis
title_sort asymptomatic ceftriaxone‐associated pseudolithiasis
publisher Wiley
series Journal of General and Family Medicine
issn 2189-7948
publishDate 2019-09-01
description Abstract An 88‐year‐old woman with a history of meningioma and dementia was admitted with high fever, loss of appetite, and nausea in July. Urinary tract infection was suspected. Computed tomography (CT) showed no significant findings. Urinary findings improved with administration of ceftriaxone. However, high fever appeared on hospital day 28, and CT identified a gallbladder stone without any abdominal symptoms. We considered the possibility of ceftriaxone‐associated pseudolithiasis and changed pharmacotherapy to cefmetazole. CT on day 34 showed a reduction in the size of the gallbladder stone. Ceftriaxone‐associated pseudolithiasis might arise in the absence of abdominal symptoms, and clinicians should take the patient background and season into account when using this agent.
topic asymptomatic
ceftriaxone
high temperature
pseudolithiasis
url https://doi.org/10.1002/jgf2.269
work_keys_str_mv AT osamusasaki asymptomaticceftriaxoneassociatedpseudolithiasis
AT kazunorisugimura asymptomaticceftriaxoneassociatedpseudolithiasis
AT masahiroshinoda asymptomaticceftriaxoneassociatedpseudolithiasis
AT masaharushinkai asymptomaticceftriaxoneassociatedpseudolithiasis
_version_ 1725881707637243904